Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Download White Paper
IT in
Healthcare,
Patient
Monitoring &
Telemedicine

Download White Paper

 
Matching geography
Reports matching your search in:
 
 
Download SlideShare
20
Hot
Stats on
Healthcare
IT

Download SlideShare

 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Emerging Technology: market research reports

1594
RSS Feeds

Emerging Technology market research reports and industry analysis

< prev 1  2  3  4  5  next >
Genetic Diseases and Pharmacogenomics
2/1/2010 | published by: Venture Planning Group
... products. Contains 75 pages and 1 table Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.  |  read more...
$900.00
MicroRNA Research and Disease Associations 2010 Market Report
1/1/2010 | published by: Select Biosciences Limited
... the microRNA research marketplace including market penetrance of different research product vendors into the end-user community, products for microRNA research in the various market segments, research market characteristics—number of experiments performed, research product pricing, segmentation ...  |  read more...
$2,600.00
U.S. Epigenetics Markets
12/31/2009 | published by: Frost & Sullivan
... and chromatin immunoprecipitation segments. Each segment covers competitive structure, market share analysis, revenue forecasts, and product analysis. The key market drivers and restraints, challenges, strategies, and competitive factors are covered for the total market overview.  |  read more...
$6,000.00
Biomarker and Diagnostic Opportunities Associated with Targeted Cancer Therapies
12/21/2009 | published by: Decision Resources
... and inform drug safety and efficacy, provide information on disease progression, and aid in the diagnosis of a cancer. The critical role of biomarkers in targeted cancer therapies is underscored by oncologists we surveyed for ...  |  read more...
$4,600.00
Innovations In Epigenetics: Advances in Technologies, Diagnostics & Therapeutics
11/26/2009 | published by: Business Insights
... and influence disease progression. Three main mechanisms - DNA methylation, histone modifications and changes in non-coding RNA - have been elucidated in epigenetics. Each in its own way may provide the industry with a greater ...  |  read more...
$3,835.00
Business Trends: Pharmaceuticals Technology Understanding Your Life Sciences Customer, 2009 (Customer Focus)
11/25/2009 | published by: Datamonitor
... on the results of Ovum's Business Trends primary research, conducted in Q3 and Q4 2009, with a total of 150 life sciences companies. Scope In-depth interviews with 150 pharmaceutical and biotechnology companies Geographic coverage includes: ...  |  read more...
$3,395.00
Future of Green Biotechnology in China
10/19/2009 | published by: CCM International Limited
... this report is finished soon in October 2009. Green biotechnology (GB) is mainly based on genetically modified technology and fermentation technology. Over the last thirty years, China’s GB industry has been developing stably. Chinese scientists ...  |  read more...
$6,650.00
The Global Bioinformatics Market: Market size, forecasts and company profiles
9/1/2009 | published by: Business Insights
... manufacturers to use effective technologies that will help them to develop successful therapies. The market players are collaborating with each other to develop block buster technologies while utilizing this synergy to reduce cost. This report ...  |  read more...
$3,835.00
The 2010-2015 World Outlook for Biochips
7/7/2009 | published by: Icon Group International, Inc.
... (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ...  |  read more...
$795.00
The 2009-2014 World Outlook for Gene Amplification Technologies
7/7/2009 | published by: Icon Group International, Inc.
... in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ...  |  read more...
$795.00
Nanopatterning
7/1/2009 | published by: Global Industry Analysts
... Soft Lithography, & Others), Scanning Probe Lithography, and Other. Annual forecasts are provided for the period of 2005 through 2015. The report profiles 28 companies including many key and niche players worldwide such as Ambios ...  |  read more...
$3,950.00
Controlled-release: Players, products & prospects to 2018 (Volume I)
6/26/2009 | published by: Espicom Healthcare Intelligence
This major strategic analysis provides a detailed insight into the current and future market for controlled-release drug delivery technology.  |  read more...
$1,040.00
Nucleic Acid Drug Delivery Technologies: Players, products & prospects to 2018 (Volume III)
6/26/2009 | published by: Espicom Healthcare Intelligence
This major strategic analysis provides a detailed insight into the current and future market for nucleic acid drug delivery technology.  |  read more...
$1,040.00
Targeted Drug Delivery Technologies: Players, products & prospects to 2018 (Volume IV)
6/26/2009 | published by: Espicom Healthcare Intelligence
This major strategic analysis provides a detailed insight into the current and future market for targeted drug delivery technology.  |  read more...
$1,040.00
Pharmacogenomics for Clinical Use and in Drug Development
6/1/2009 | published by: TriMark Publications
... based on their particular responses to a drug. The knowledge of the likely effectiveness of a drug in a patient makes the drug more reliable, and fewer drugs would have to be taken off the ...  |  read more...
$3,400.00
Key Trends In Drug-diagnostic Co-development: Identifying collaborative opportunities and navigating regulatory challenges
6/1/2009 | published by: Business Insights
... The potential for molecular diagnostics to be used as companion products for personalized treatments that are based on patient characteristics will contribute to a growing trend for new partnerships between drug companies and diagnostic firms. ...  |  read more...
$3,835.00
Therapeutic Peptides in Oncology - Favorable Conditions But Where to Commercialize?
5/28/2009 | published by: BioSeeker Group AB
... report identifies the competitive terrain for cancer therapeutic peptides to be wide open from a compound perspective and the opportunity for peptide drugs to challenge other biologicals such as antibodies is real and significant. This ...  |  read more...
$3,553.00
The World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition
5/1/2009 | published by: Kalorama Information
... nearly 7 million people die. The most common cancers affecting the world include lung, breast, colon/rectum, stomach, liver, prostate, cervical, esophageal, and bladder. This Kalorama Information report - The World Market for Cancer Therapeutics and ...  |  read more...
$995.00
Assessment of Innovations in Biochips (Technical Insights)
3/31/2009 | published by: Frost & Sullivan
This research service discusses the assessment of innovations in biochips.  |  read more...
$6,500.00
Technological Advances in Microscopy (Technical Insights)
3/30/2009 | published by: Frost & Sullivan
... challenges associated with this industry. This research service elaborates on the current and future trends of the industry and substantiates the findings with examples of technical progress in the field of biological sciences. The application ...  |  read more...
$6,500.00
Competitor Analysis: Amyotrophic Lateral Sclerosis (ALS) / Lou Gehrig's disease
3/28/2009 | published by: La Merie Publishing
... as of March 2009. Amyotrophic lateral sclerosis (ALS, also called Lou Gehrig's disease) is a rapidly progressing, motor neuron disease characterized by the gradual degeneration and death of motor neurons. When muscles in the diaphragm ...  |  read more...
$275.00
The Future of Biobanks: Regulation, ethics, investment and the humanization of drug discovery
3/9/2009 | published by: Business Insights
... years, large population-based biobanks have been established which monitor the health status of participants over time to assess the natural occurrence and progression of common diseases. Hundreds of disease-based biobanks are located around the world, ...  |  read more...
$3,835.00
MarketWatch: Biotechnology
2/17/2009 | published by: Datamonitor
... insight into the key events in the Biotechnology industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in the Biotechnology industry.  |  read more...
$200.00
The 2009-2014 World Outlook for Chiral-Based Products
1/8/2009 | published by: Icon Group International, Inc.
... question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ...  |  read more...
$795.00
The 2009 Report on Chiral-Based Products: World Market Segmentation by City
1/5/2009 | published by: Icon Group International, Inc.
... as opposed to regions, continents, or countries. This report covers the top 2000 cities in over 200 countries. It does so by reporting the estimated market size (in terms of latent demand) for each major ...  |  read more...
$795.00
< prev 1  2  3  4  5  next >